Physiologic regulation and pathologic disorders of fibrinolysis

This publication has 45 references indexed in Scilit:

• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION
  The Lancet, 1985
• Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.
  Journal of Clinical Investigation, 1985
• The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.
  Proceedings of the National Academy of Sciences, 1984
• Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction
  Journal of the American College of Cardiology, 1984
• Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species.
  Journal of Clinical Investigation, 1984
• Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction
  New England Journal of Medicine, 1984
• Tissue Plasminogen Activator: Chemical and Physiological Aspects
  Seminars in Thrombosis and Hemostasis, 1984
• The fibrinolytic system—Basic considerations
  Progress in Cardiovascular Diseases, 1979
• The Demise of John Hageman
  New England Journal of Medicine, 1968